Nuwellis Inc (NUWE)

$4.34 -0.43 (-9.01%)
Market Cap 4.41M
Revenue (ttm) 8.74M
Net Income (ttm) -11.17M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -127.80%
Debt to Equity Ratio 0.00
Volume 1,429,841
Avg Vol 1,030,468
Day's Range N/A - N/A
Shares Out 903,000.00
Stochastic %K 17%
Beta 0.18
Analysts Hold
Price Target $11.00

Company Profile

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and...

Industry: Medical Devices
Sector: Healthcare
Phone: 952 345 4200
Address:
12988 Valley View Road, Eden Prairie, United States
Russell007xx
Russell007xx Sep. 9 at 9:46 PM
$NUWE haha. Like I said this morning, this will go under , take my advise and don’t invest a single penny on this
0 · Reply
Jacks10
Jacks10 Sep. 9 at 8:54 PM
$NUWE WTH! When does this manipulation stop!
0 · Reply
MrTicker
MrTicker Sep. 9 at 6:07 PM
$NUWE Solid PR. Should see afternoon recovery. Volume needs to pick up to increase buying pressure to break $4.50+ level.
0 · Reply
_www_larval_com_
_www_larval_com_ Sep. 9 at 6:02 PM
$NUWE has stumbled -4% lower to -11% (~1Mv) in the last few minutes, follow for more volatility.
0 · Reply
GluttonBoy
GluttonBoy Sep. 9 at 5:23 PM
TAIT stock is at zero borrow with shorts trapped and about to have a historic squeeze 3M float with no dilution and is a profitable semiconductor play $NUWE $SSM $BGLC $HWH $DHAI all on watch with dips
0 · Reply
done84
done84 Sep. 9 at 2:30 PM
$NUWE nothing has changed here. Still toxic games and investors getting robbed. Business as usual. Scam. 🖕🖕
0 · Reply
done84
done84 Sep. 9 at 2:28 PM
$NUWE criminls. Rot in hell CHFS or NUWE or whatever you pos! 🖕🖕
0 · Reply
bazooka007
bazooka007 Sep. 9 at 2:26 PM
$NUWE any explanation for this massacre?
0 · Reply
GluttonBoy
GluttonBoy Sep. 9 at 2:17 PM
TAIT stock is at zero borrow with shorts trapped and about to have a historic squeeze 3M float with no dilution and is a profitable semiconductor play $XTIA $CYCU $ISPC $NUWE $PSTV on watch
0 · Reply
Russell007xx
Russell007xx Sep. 9 at 2:12 PM
$NUWE wish you were listening
0 · Reply
Latest News on NUWE
Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Sep 9, 2025, 9:00 AM EDT - 9 hours ago

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Sep 4, 2025, 8:15 AM EDT - 5 days ago

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Aug 21, 2025, 8:15 AM EDT - 19 days ago

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Aug 19, 2025, 8:15 AM EDT - 21 days ago

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Aug 15, 2025, 8:15 AM EDT - 25 days ago

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 2:37 PM EDT - 26 days ago

Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 14, 2025, 8:15 AM EDT - 26 days ago

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Aug 7, 2025, 8:15 AM EDT - 4 weeks ago

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Aug 6, 2025, 8:15 AM EDT - 4 weeks ago

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Aug 5, 2025, 8:15 AM EDT - 5 weeks ago

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Nuwellis Stockholders Approve All Proposals at Special Meeting

Aug 4, 2025, 5:24 PM EDT - 5 weeks ago

Nuwellis Stockholders Approve All Proposals at Special Meeting

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Jul 23, 2025, 8:45 AM EDT - 6 weeks ago

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Jul 23, 2025, 8:15 AM EDT - 6 weeks ago

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Jul 22, 2025, 8:15 AM EDT - 7 weeks ago

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Jul 17, 2025, 7:35 AM EDT - 7 weeks ago

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Jul 15, 2025, 4:05 PM EDT - 2 months ago

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Nuwellis Appoints John Erb as Chief Executive Officer

Jul 2, 2025, 8:15 AM EDT - 2 months ago

Nuwellis Appoints John Erb as Chief Executive Officer

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Jun 10, 2025, 4:15 PM EDT - 3 months ago

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

Jun 9, 2025, 9:15 AM EDT - 3 months ago

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

May 13, 2025, 10:50 AM EDT - 4 months ago

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

May 13, 2025, 7:00 AM EDT - 4 months ago

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

May 12, 2025, 7:00 AM EDT - 4 months ago

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

May 8, 2025, 7:00 AM EDT - 4 months ago

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

Apr 24, 2025, 7:00 AM EDT - 4 months ago

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

Apr 22, 2025, 4:05 PM EDT - 5 months ago

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 12:23 PM EDT - 6 months ago

Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

Mar 11, 2025, 8:00 AM EDT - 6 months ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

Feb 24, 2025, 4:05 PM EST - 7 months ago

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

Feb 20, 2025, 8:00 AM EST - 7 months ago

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Feb 18, 2025, 4:15 PM EST - 7 months ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 11:02 AM EST - 10 months ago

Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

Nov 11, 2024, 8:00 AM EST - 10 months ago

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nov 5, 2024, 9:28 AM EST - 11 months ago

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Nov 4, 2024, 8:30 AM EST - 11 months ago

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Nuwellis Announces Preliminary Results for Third Quarter of 2024

Nov 1, 2024, 4:15 PM EDT - 11 months ago

Nuwellis Announces Preliminary Results for Third Quarter of 2024

Nuwellis Welcomes University of Iowa Health Care Stead Family Children's Hospital as Newest Pediatric Customer

Oct 31, 2024, 8:00 AM EDT - 11 months ago

Nuwellis Welcomes University of Iowa Health Care Stead Family Children's Hospital as Newest Pediatric Customer

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

Oct 23, 2024, 4:15 PM EDT - 11 months ago

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference

Sep 25, 2024, 4:15 PM EDT - 1 year ago

Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Aug 23, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Nuwellis, Inc. (NUWE) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 12:39 PM EDT - 1 year ago

Nuwellis, Inc. (NUWE) Q2 2024 Earnings Call Transcript

Nuwellis, Inc. Announces Second Quarter 2024 Financial Results

Aug 13, 2024, 8:00 AM EDT - 1 year ago

Nuwellis, Inc. Announces Second Quarter 2024 Financial Results

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical's QUELIMMUNE™ Therapy at Cincinnati Children's

Jul 26, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical's QUELIMMUNE™ Therapy at Cincinnati Children's

Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules

Jul 24, 2024, 8:02 AM EDT - 1 year ago

Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules

Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024

Jul 23, 2024, 4:10 PM EDT - 1 year ago

Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children's

Jul 17, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children's

Nuwellis Announces Reverse Stock Split

Jun 26, 2024, 8:45 AM EDT - 1 year ago

Nuwellis Announces Reverse Stock Split

Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™

Jun 25, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™

DaVita, Nuwellis Extend Pilot Collaboration for Aquadex

Jun 11, 2024, 12:46 PM EDT - 1 year ago

DaVita, Nuwellis Extend Pilot Collaboration for Aquadex

DVA

Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase

Jun 6, 2024, 9:00 AM EDT - 1 year ago

Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase

Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida

May 14, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida

Russell007xx
Russell007xx Sep. 9 at 9:46 PM
$NUWE haha. Like I said this morning, this will go under , take my advise and don’t invest a single penny on this
0 · Reply
Jacks10
Jacks10 Sep. 9 at 8:54 PM
$NUWE WTH! When does this manipulation stop!
0 · Reply
MrTicker
MrTicker Sep. 9 at 6:07 PM
$NUWE Solid PR. Should see afternoon recovery. Volume needs to pick up to increase buying pressure to break $4.50+ level.
0 · Reply
_www_larval_com_
_www_larval_com_ Sep. 9 at 6:02 PM
$NUWE has stumbled -4% lower to -11% (~1Mv) in the last few minutes, follow for more volatility.
0 · Reply
GluttonBoy
GluttonBoy Sep. 9 at 5:23 PM
TAIT stock is at zero borrow with shorts trapped and about to have a historic squeeze 3M float with no dilution and is a profitable semiconductor play $NUWE $SSM $BGLC $HWH $DHAI all on watch with dips
0 · Reply
done84
done84 Sep. 9 at 2:30 PM
$NUWE nothing has changed here. Still toxic games and investors getting robbed. Business as usual. Scam. 🖕🖕
0 · Reply
done84
done84 Sep. 9 at 2:28 PM
$NUWE criminls. Rot in hell CHFS or NUWE or whatever you pos! 🖕🖕
0 · Reply
bazooka007
bazooka007 Sep. 9 at 2:26 PM
$NUWE any explanation for this massacre?
0 · Reply
GluttonBoy
GluttonBoy Sep. 9 at 2:17 PM
TAIT stock is at zero borrow with shorts trapped and about to have a historic squeeze 3M float with no dilution and is a profitable semiconductor play $XTIA $CYCU $ISPC $NUWE $PSTV on watch
0 · Reply
Russell007xx
Russell007xx Sep. 9 at 2:12 PM
$NUWE wish you were listening
0 · Reply
Russell007xx
Russell007xx Sep. 9 at 1:59 PM
$NUWE lol like I said
0 · Reply
Heywood_Jablomi
Heywood_Jablomi Sep. 9 at 1:54 PM
$NUWE in
0 · Reply
bazooka007
bazooka007 Sep. 9 at 1:40 PM
$NUWE wtf is going on here
0 · Reply
DARKP00L
DARKP00L Sep. 9 at 1:39 PM
$NUWE 09:06 on Sep. 09 2025 Nuwellis shares are trading higher after its development partner, Koronis Biomedical Technologies, was awarded a $3 million NIH grant. #tradeideas
0 · Reply
globaldaytraderzzz
globaldaytraderzzz Sep. 9 at 1:28 PM
$NUWE strongbuy rating at bottom
0 · Reply
Love_To_Learn
Love_To_Learn Sep. 9 at 1:20 PM
$NUWE coding this 4.31 for $SINT their special 4l31 *
0 · Reply
BB_88_
BB_88_ Sep. 9 at 1:16 PM
$NUWE what fukery is going on this morning
0 · Reply
bazooka007
bazooka007 Sep. 9 at 1:09 PM
$NUWE
0 · Reply
Russell007xx
Russell007xx Sep. 9 at 1:08 PM
$NUWE this is a scam stock an I am telling you guys be very careful
0 · Reply
Love_To_Learn
Love_To_Learn Sep. 9 at 1:08 PM
$NUWE brought metadata to u $SINT weaponizing the 4.42 anomaly $SLS
0 · Reply
mikedumbledar
mikedumbledar Sep. 9 at 1:07 PM
$NUWE you guys buying this absolute trash will never learn. stay away.
0 · Reply
Russell007xx
Russell007xx Sep. 9 at 1:06 PM
$NUWE under 4 lol
0 · Reply